Skip to main content
    P

    ProMIS Neurosciences Inc. (PMN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.31
    +0.02 (+0.61%)

    Market Cap: $29.60M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    ProMIS Neurosciences Inc. (PMN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to ProMIS Neurosciences are OS Therapies (OSTX), Gain Therapeutics (GANX) and Serina Therapeutics (SER). By market cap, ProMIS Neurosciences ranks 10th of the 13 companies on this page; Mink Therapeutics (INKT) is the largest at $47.95M.

    Peer Comparison

    PMN's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    ProMIS Neurosciences (PMN)$29.60MN/AN/A0.0%N/A0.0%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    NanoViricides Inc (NNVC)$31.41MN/AN/A0.0%N/A0.0%0.00%
    Mural Oncology plc (MURA)$35.38MN/AN/A0.0%-173.6%0.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Peer median$35.13MN/A119.2x0.0%-109.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to ProMIS Neurosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    NanoViricides Inc (NNVC)
    NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections.
    NNVC competitors
    Mural Oncology plc (MURA)
    Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors...
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors

    Frequently Asked Questions About PMN

    Who are ProMIS Neurosciences' main competitors?

    The companies most similar to ProMIS Neurosciences include OS Therapies (OSTX), Gain Therapeutics (GANX), Serina Therapeutics (SER), INmune Bio (INMB) and Immutep Ltd ADR (IMMP), listed from the closest match.

    Who is ProMIS Neurosciences' biggest competitor?

    Mink Therapeutics (INKT) is the largest of the similar companies at $47.95M; OS Therapies (OSTX) is the closest match by business profile, size, sector and industry.

    How does PMN stock compare with its competitors?

    PMN's net margin is 0.0% against a peer median of 0.0%.

    Which of ProMIS Neurosciences' competitors pays a higher dividend?

    ProMIS Neurosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is ProMIS Neurosciences bigger than its competitors?

    No. ProMIS Neurosciences is 10th by market cap among the 13 companies on this page; the largest is Mink Therapeutics (INKT) at $47.95M.